Article
Outcome measure of clinical trial of retinal prosthesis by suprachoroidal-transretinal stimulation (STS) for patients with hand-motion vision
Search Medline for
Authors
Published: | November 30, 2017 |
---|
Outline
Text
Objective: In pivotal clinical study of suprachoroidal-transretinal stimulation (STS) retinal prosthesis, we include patients with hand-motion (HM) vision. Because the main outcome measure is the result of light localization test, we have to define the optimum target contrast for evaluation. In this study we evaluated the deviation in reaching movement to a target with different contrast in a patient implanted with STS retinal prosthesis in the pilot study and investigated the optimal target contrast to evaluate the efficacy of retinal prosthesis for a patients with residual vision.
Methods: A STS retinal prosthesis was implanted in the right eye of 42-year-old man with advanced Stargardt disease with visual acuity of HM. In localization test, a white square target (visual angle; 10°) with different contrast (95, 85, 74%) was displayed on the PC monitor at a random position and the patient was instructed to touch the center of a target (20 trials). We measured the distance between the touched point and the center of a target and averaged (absolute deviation) in a condition with system ON and OFF during one-year follow-up.
Results: The absolute deviation with system ON was not always smaller than that with system OFF for a high contrast target (96%) but was always smaller with system ON than system OFF for a low contrast target (85%, 74%).
Discussion: Low-contrast target may be better to evaluate the accuracy of localization in patients implanted with retinal prosthesis and with residual natural vision.
Acknowledgement: This work was supported by AMED grant, Japan